Heterozygous P0 knockout mice develop a peripheral neuropathy that resembles chronic inflammatory demyelinating polyneuropathy (CIDP)

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 7, 1997, Pages 811-821

  Shy, Michael E ^a   Arroyo, Edgardo ^b   Sladky, John ^c   Menichella, Daniela ^a,d   Jiang, Huiyuan ^a   Xu, Wenbo ^a   Kamholz, John ^a   Scherer, Steven S ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Axon Schwann cell interactions; Cheroot Marie Tooth disease; CMT; Conduction block; Demyelination; My elin; Schwann cells

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DEMYELINATING DISEASE; HETEROZYGOSITY; MOTOR NERVE BLOCK; MOUSE; NONHUMAN; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; PRIORITY JOURNAL; REVIEW; SCIATIC NERVE; ACTION POTENTIAL; AGING; ANIMAL; ARTICLE; CHRONIC DISEASE; DISEASE MODEL; GENETICS; INFLAMMATION; MOUSE MUTANT; NERVE CONDUCTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME;

ACTION POTENTIALS; AGING; ANIMALS; CHRONIC DISEASE; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; INFLAMMATION; MICE; MICE, KNOCKOUT; NEURAL CONDUCTION; SCIATIC NERVE; TIME FACTORS;

EID: 0030611992     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199756070-00008     Document Type: Review

References (38)

1. Suter U, Snipes GJ. Biology and genetics of hereditary motor and sensory neuropathies. Annu Rev Neurosci 1995;18:45-75
2. Scherer SS. New wrinkles on an old membrane. Neuron 1997;18:13-16
3. Ad hoc Subcommittee of the American Academy of Neurology. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;41:617-18
4. Austin JH. Recurrent polyneuropathies and their corticosteroid treatment. Brain 1957ic;81:158-92
5. McCombe PA, Pollard JD, McLeod JG. Chronic inflammatory demyelinating polyradiculoneuropathy. Brain 1987;110:1617-30
6. Dyck P, Prineas J, Pollard J. Chronic inflammatory demyelinating polyradiculoneuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, eds. Peripheral neuropathy. Philadelphia: W.B. Saunders, 1993:1498-1517
7. Mendell JR. Chronic inflammatory demyelinating polyradiculoneuropathy. Annu Rev Med 1993;44:211-19
8. Bonnaud E, Vital C, Cohere G, Castaing R, Loiseau P. Recurrent and relapsing polyneuritis. Four cases with ultrastructural studies of the peripheral nerves. Path Europ 1974;9:109-18
9. Prineas JW. Demyelination and remyelination in recurrent idiopathic polyneuropathy: An electron microscope study. Acta Neuropathol 1971;18:34-57
10. Prineas JW, McLeod JG. Chronic relapsing polyneuritis. J Neurol Sci 1976;27:427-58
11. Krendel DA, Parks HP, Anthony DC, St. Clair MB, Graham DG. Sural nerve biopsy in chronic inflammatory polyradiculoneuropathy. Muscle Nerve 1989;12:257-64
12. Latov N, Sherman WH, Nemni R, et al. Plasma-cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheralnerve myelin. N Eng J Med 1980;303:618-21
13. Heininger K, Liebert UG, Toyka KV, et al. Chronic inflammatory polyneuropathy: Reduction of nerve conduction velocities in monkeys by systemic passive transfer of immunoglobulin G. J Neurol Sci 1984;66:1-14
14. Koski CL, Humphrey R, Shin ML. Anti-peripheral myelin antibody in patients with demyelinating neuropathy: Quantitative and kinetic determination of serum antibody by complement fixation. Proc Natl Acad Sci USA 1985;82:905-9
15. Toyka KV, Heininger K. Humoral factors in peripheral nerve disease. Muscle Nerve 1987;10:222-32
16. 0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 1992;71:565-76
17. Rhee EK, England JD, Sumner AJ. A computer simulation of conduction block: Effects produced by actual block versus interphase cancellation. Ann Neurol 1990;28:146-56
18. Martini R, Zielasek J, Toyka KV, Giese KP, Schachner M. Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat Genet 1995;11:281-85
19. 0 gene mutations. Muscle Nerve 1996;19:946-52
20. Lewis RA, Sumner AJ. The electrodiagnostic distinctions between chronic familial and acquired demyelinating neuropathies. Neurology 1982;32:592-96
21. Welch BL. The generalization of Student's problem when different population variances are involved. Biometrika 1947;34:28-35
22. Kaku DA, Parry GJ, Malamut R, Lupski JR, Garcia CA. Uniform slowing of conduction velocities in Charcot-Marie-Tooth disease polyneuropathy type 1. Neurology 1993;434:2664-67
23. Webster HdeF, Schroder JM, Asbury AK, Adams RD. The role of Schwann cells in the formation of "onion bulbs" found in chronic neuropathies. J Neuropathol Exp Neurol 1967;26:276-99
24. Webster HdeF. Development of peripheral nerve fibers.In: Dyck PJ, Thomas PK, Low PA, Poduslo JF, eds. Peripheral neuropathy. Philadelphia: W.B. Saunders, 1993:243-66
25. Schmalbruch H. Fiber composition of rat sciatic nerve. Anat Rec 1986;215:71-81
26. Griffin JW, Huffman PN. Degeneration and regeneration in the peripheral nervous system. In: Dyck PJ, Thomas PK, Low PA, Poduslo JF, eds. Peripheral neuropathy. Philadelphia: W.B. Saunders, 1993:361-76
27. Ikegami T, Nicholson G, Ikeda H, et al. A novel homozygous mutation of the myelin P0 gene producing Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). Biochem Biophys Res Commun 1996;222:107-10
28. 0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron 1996;17:451-60
29. Scherer SS, Chance PF. Myelin genes: Getting the dose right. Nat Genet 1995;11:226-28
30. Albers JW, Kelley JJ, Jr. Acquired inflammatory demyelinating polyneuropathies: Clinical and electrodiagnostic features. Muscle Nerve 1989;12:435-51
31. Dyck PJ, Chance P, Lebo R, Carney JA. Hereditary motor and sensory neuropathies. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, eds. Peripheral neuropathy. Philadelphia: W.B. Saunders, 1993:1094-1136
32. Gabreels-Festen AAWM, Gabreels FJM, Hoogendijk JE, Bolhuis PA, Jongen PJH, Vingerhoets HM. Chronic inflammatory demyelinating polyneuropathy or hereditary motor and sensory neuropathy - Diagnostic value of morphological criteria. Acta Neuropathol 1993;86:630-35
33. Dyck PJ, Swanson CJ, Low PA, Bartleson JD, Lambert EH. Prednisone-responsive hereditary motor and sensory neuropathy. Mayo Clin Proc 1982;57:239-46
34. Mitchell GW, Bosch EP, Hart MN. Response to immunosuppressive therapy in patients with hereditary motor and sensory neuropathy and associated dysimmune neuromuscular disorders. Eur Neurol 1987;27:188-96
35. Waddy HM, Misra VP, King RH, Thomas PK, Middleton L, Ormerod IE. Focal cranial nerve involvement in chronic inflammatory demyelinating polyneuropathy: Clinical and MRI evidence of peripheral and central lesions. J Neurol 1989;236:400-405
36. Bird SJ, Sladky JT. Corticosteroid-responsive dominantly inherited neuropathy in childhood. Neurology 1991;41:437-39
37. Vital A, Vital C, Julien J, Fontana D. Occurrence of active demyelinating lesions in children with hereditary motor and sensory neuropathy (HMSN) Type 1. Acta Neuropathol 1992;84:433-36
38. Schwanz M, Sela BA, Eshhar N. Antibodies to gangliosides and myelin autoantigens are produced in mice following sciatic nerve injury. J Neurochem 1982;38:1192-95